1M0Z
Crystal Structure of the von Willebrand Factor Binding Domain of Glycoprotein Ib alpha
Summary for 1M0Z
Entry DOI | 10.2210/pdb1m0z/pdb |
Related | 1M10 |
Descriptor | Glycoprotein Ib alpha (2 entities in total) |
Functional Keywords | leucine-rich repeat, hemostasis, blood clotting |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P07359 |
Total number of polymer chains | 2 |
Total formula weight | 64733.82 |
Authors | Huizinga, E.G.,Tsuji, S.,Romijn, R.A.P.,Schiphorst, M.E.,de Groot, P.G.,Sixma, J.J.,Gros, P. (deposition date: 2002-06-16, release date: 2002-08-28, Last modification date: 2021-11-10) |
Primary citation | Huizinga, E.G.,Tsuji, S.,Romijn, R.A.,Schiphorst, M.E.,de Groot, P.G.,Sixma, J.J.,Gros, P. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science, 297:1176-1179, 2002 Cited by PubMed Abstract: Transient interactions of platelet-receptor glycoprotein Ibalpha (GpIbalpha) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbalpha amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbalpha wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs. PubMed: 12183630DOI: 10.1126/science.107355 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.85 Å) |
Structure validation
Download full validation report